Cargando…

Male breast cancer: finding the way in this uncommon path

Detalles Bibliográficos
Autores principales:	Maurer, Christian, Martel, Samuel, de Azambuja, Evandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	ESMO Open 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5519817/ https://www.ncbi.nlm.nih.gov/pubmed/28761736 http://dx.doi.org/10.1136/esmoopen-2017-000169

Ejemplares similares

Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer
por: Eiger, Daniel, et al.
Publicado: (2020)

Atezolizumab in metastatic triple-negative breast cancer: IMpassion130 and 131 trials - how to explain different results?
por: Franzoi, Maria Alice, et al.
Publicado: (2020)

Controversies in oncology: which adjuvant endocrine therapy is to be given to premenopausal patients with hormone receptor-positive breast cancer?
por: Lambertini, Matteo, et al.
Publicado: (2018)

Controversies in Oncology: Surgery of the primary tumour in patients presenting with de novo metastatic breast cancer: to do or not to do?
por: Poggio, Francesca, et al.
Publicado: (2018)

CDK4/6 inhibition in HR-positive early breast cancer: are we putting all eggs in one basket?
por: Agostinetto, Elisa, et al.
Publicado: (2020)

A Male Patient With Breast Hamartoma: An Uncommon Finding
por: Phan, Vincent T, et al.
Publicado: (2020)

I-SPY 2: optimising cancer drug development in the 21st century
por: Bartsch, Rupert, et al.
Publicado: (2016)

Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis
por: Brandão, Mariana, et al.
Publicado: (2020)

Imaging findings and classification of the common and uncommon male breast diseases
por: Önder, Ömer, et al.
Publicado: (2020)

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis
por: Poggio, Francesca, et al.
Publicado: (2018)

Making of a perfectionist maxillofacial surgeon – path and ways
por: Deshmukh, Vijay
Publicado: (2022)

Threat posed by unproven drugs in medical oncology
por: Pondé, Noam, et al.
Publicado: (2016)

A path uncommonly traveled
por: Appasani, Sreekanth, et al.
Publicado: (2013)

Uncommon paths in quantum physics
por: Kazakov, Konstantin V
Publicado: (2014)

Looking backward to find the path forward
por: Furey, Ambrose, et al.
Publicado: (2010)

Pseudoangiomatous Stromal Hyperplasia (PASH) of the Breast: An Uncommon Finding in an Uncommon Patient
por: Surace, Alessandra, et al.
Publicado: (2020)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Finding a way in the information age
Publicado: (2019)

Finding a way forward in the community
por: Waite, Charlotte
Publicado: (2020)

EGFR Reloaded: Finding New Ways to Shape Pancreatic Cancer Epigenome
por: LaRue, Kayla C., et al.
Publicado: (2023)

Reply to: PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2023)

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer
por: Maurer, Christian, et al.
Publicado: (2018)

Prognostic Factors Research in Breast Cancer Patients: New Paths
por: Susini, Tommaso, et al.
Publicado: (2022)

Oncofertility counselling in premenopausal women with HER2-positive breast cancer
por: Lambertini, Matteo, et al.
Publicado: (2019)

Common border, uncommon paths : race, culture, and national identity in U.S.-Mexican relations /
Publicado: (1997)

The Exciting New Field of HER2-Low Breast Cancer Treatment
por: Eiger, Daniel, et al.
Publicado: (2021)

Solitary adrenal metastasis from invasive ductal breast cancer: an uncommon finding
por: Liu, Xiao-Jiao, et al.
Publicado: (2010)

Lipoma of the Palate: An Uncommon Finding
por: Volpato, Luiz Evaristo Ricci, et al.
Publicado: (2016)

PREDICT underestimates survival of patients with HER2-positive early-stage breast cancer
por: Agostinetto, Elisa, et al.
Publicado: (2022)

Prophylactic cranial irradiation in breast cancer: A new way forward
por: Gandhi, Ajeet Kumar, et al.
Publicado: (2015)

Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
por: Snoj, Natasa, et al.
Publicado: (2009)

Evidence in Urologic- and Pelvic-Surgery Research: Finding the IDEAL Way of Reporting
por: Gerullis, H., et al.
Publicado: (2017)

Uncommon ophthalmology - Care for the rare
por: Honavar, Santosh G
Publicado: (2022)

From Genetics to Precision Therapy: Finding a Path through the Scientific Valley of Death
por: Gupta, Ritika, et al.
Publicado: (2019)

Neoadjuvant treatment for male breast cancer
por: Fentiman, Ian Stuart
Publicado: (2023)

Emerging issues related to COVID-19 vaccination in patients with cancer
por: Saini, Kamal S., et al.
Publicado: (2021)

Gastric Pseudomelanosis: An Uncommon Finding
por: Samies, John, et al.
Publicado: (2022)

Gastrointestinal Stromal Tumor (GIST) Causing Obscure Gastrointestinal Bleeding: An Uncommon Way of Diagnosing An Uncommon Disease
por: Dziadkowiec, Karolina N, et al.
Publicado: (2020)

Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
por: Kourie, Hampig Raphael, et al.
Publicado: (2017)

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives
por: Caparica, Rafael, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sheslitt6nm5dcg3s9b6rq31mc